Yayınlar & Eserler

Yayın Ağı
Makaleler 45
Tümü (45)
SCI-E, SSCI, AHCI (40)
SCI-E, SSCI, AHCI, ESCI (41)
ESCI (1)
Scopus (42)
TRDizin (6)

1. Development and in vivo evaluation of a novel semi-solid nanostructured lipid carrier of fluticasone propionate for the treatment of atopic dermatitis using a quality by design approach

Amasya G., Badilli U., Şengel Türk C. T., Onay-Besikci A., Aksu B., Tarimci N.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.114, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

2. Optimization of Semi-Solid Lipid Nanoparticle Dispersions by Quality by Design Approach for Dermal Delivery of Curcumin

BADILLI F. U., Sen A., Yegen G., GÜVEN ÇİLOĞLU B., Aksu B., Onay Besikci A.
Journal of Cluster Science , cilt.36, sa.5, 2025 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

3. Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection FractionS

Güven B., Sun Q., Wagg C. S., Almeida de Oliveira A., Silver H., Persad K. L., et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS , cilt.388, sa.1, ss.145-155, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

4. Past and present of beta arrestins: A new perspective on insulin secretion and effect.

GÜVEN B., Onay-Besikci A.
European journal of pharmacology , cilt.956, ss.175952, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

5. In Vitro and in Silico Evaluation of Some New 1H-Benzimidazoles Bearing Thiosemicarbazide and Triazole as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

ÇELİK İ., Ayhan-Kilcigil G., GÜVEN B., Kara Z., Onay-Besikci A.
POLYCYCLIC AROMATIC COMPOUNDS , cilt.43, sa.1, ss.444-455, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

6. SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir

Gülten E., Çelik İ., Beşikci A., Çınar G., Akdemir Kalkan İ., Kılcıgil G., et al.
Infectious diseases and clinical microbiology (Online) , cilt.4, sa.3, ss.185-191, 2022 (TRDizin) identifier

7. A no-filter snapshot of drug-related problems in Ankara University Hospitals

TEZGELEN A. S., KAYRA T., ÜRKMEZ F., Akyol B., TOPALOĞLU İ. E., RAHVAN H., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.44, sa.3, ss.797, 2022 (SCI-Expanded, Scopus) identifier

8. Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes

Kara Z., GÜVEN B., BEŞİKCİ A., YILDIRIM N., ALTUNAY H.
EUROPEAN JOURNAL OF PHARMACOLOGY , cilt.916, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

9. Synthesis, molecular docking, in silico ADME, and EGFR kinase inhibitor activity studies of some new benzimidazole derivatives bearing thiosemicarbazide, triazole, and thiadiazole

ÇELİK İ., Ayhan-Kilcigil G., Karayel A., GÜVEN B., BEŞİKCİ A.
JOURNAL OF HETEROCYCLIC CHEMISTRY , cilt.59, sa.2, ss.371-387, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

10. Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study

ÇELİK İ., Onay-Besikci A., Ayhan-Kilcigil G.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , cilt.39, sa.15, ss.5792-5798, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. Pattern of systemic antibiotic use and potential drug interactions: evaluations through a point prevalence study in Ankara University Hospitals

AKDEMİR KALKAN İ., ÇINAR G., PEHLİVANLI A., ÜRKMEZ F., TOPALOĞLU İ. E., Akyol B., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.2, ss.523-529, 2021 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

12. HİPERTANSİYON TEDAVİ YÖNETİMİNDE ECZACININ ROLÜ: AİLE SAĞLIĞI MERKEZİ’NDE BİR MODEL UYGULAMASI

PEHLİVANLI A., Akyol B., Sesyılmaz Ö., Göçün Ö., BEŞİKCİ A., ÖZÇELİKAY A. T., et al.
Journal of Faculty of Pharmacy of Ankara University , cilt.45, sa.1, ss.1-11, 2021 (Scopus, TRDizin) identifier identifier

13. Metabolic effects of carvedilol through beta-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts

GÜVEN B., Kara Z., BEŞİKCİ A.
BRITISH JOURNAL OF PHARMACOLOGY , cilt.177, sa.24, ss.5580-5594, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

14. Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors

ÇELİK İ., KILCIGİL G., GÜVEN B., Kara Z., Gurkan-Alp A. S., KARAYEL A., et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.173, ss.240-249, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

15. QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment

AMASYA G., Aksu B., BADILLI F. U., BEŞİKCİ A., Tarimci N.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.563, ss.110-121, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

16. Orbital Cellulitis Accompanied by a Non-Symptomatic Drug Interaction That Promptly Responded to Drug Modification

AKDEMİR K. İ., AKYOL B., YILMAZ F., BEŞİKCİ A., MEMİKOĞLU K. O.
Turkiye Klinikleri Journal of Case Reports , cilt.27, sa.2, ss.95-98, 2019 (TRDizin)

17. THERMOSENSITIVE IN SITU GEL FORMULATION CONTAINING PLGA NANOPARTICLES OF FLURBIPROFEN FOR OCULAR DELIVERY

Aydin E., BADILLI F. U., BEŞİKCİ A., Tarimci N.
ACTA POLONIAE PHARMACEUTICA , cilt.75, sa.1, ss.141-153, 2018 (SCI-Expanded, Scopus) identifier identifier

18. Synthesis and Pharmacologic Evaluation of Some Benzimidazole Acetohydrazide Derivatives as EGFR Inhibitors

Demirel S., KILCIGİL G., Kara Z., GÜVEN B., BEŞİKCİ A.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.14, sa.3, ss.285-289, 2017 (ESCI, Scopus, TRDizin) identifier identifier identifier

19. Evaluation of three-layered doxycycline-collagen loaded nanofiber wound dressing

TORT S., ACARTÜRK F., BEŞİKCİ A.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.529, sa.1-2, ss.642-653, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

20. Skin Localization of Lipid Nanoparticles (SLN/NLC): Focusing the Influence of Formulation Parameters

AMASYA G., Sandri G., BEŞİKCİ A., BADILLI F. U., Caramella C., Bonferoni M. C., et al.
CURRENT DRUG DELIVERY , cilt.13, sa.7, ss.1100-1110, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

21. Calcipotriol-captisol inclusion complex and corticosteroid in a novel fixed dose combination: evaluation on human epidermal keratinocyte cells

BADILLI F. U., BEŞİKCİ A., AMASYA G., Sen T., Tarimci N.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY , cilt.83, sa.3-4, ss.363-368, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

22. Activating PPAR alpha Prevents Post-Ischemic Contractile Dysfunction in Hypertrophied Neonatal Hearts

Lam V. H., Zhang L., Huqi A., Fukushima A., Tanner B. A., BEŞİKCİ A., et al.
CIRCULATION RESEARCH , cilt.117, sa.1, ss.41-51, 2015 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

23. Effect of Fatty Acids on Human Bone Marrow Mesenchymal Stem Cell Energy Metabolism and Survival

Fillmore N., Huqi A., Jaswal J. S., Mori J., Paulin R., Haromy A., et al.
PLOS ONE , cilt.10, sa.3, 2015 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

24. Development of Etofenamate-Loaded Semisolid SLN Dispersions and Evaluation of Anti-Inflammatory Activity for Topical Application

BADILLI F. U., ŞENGEL TÜRK C. T., BEŞİKCİ A., Tarimci N.
CURRENT DRUG DELIVERY , cilt.12, sa.2, ss.200-209, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

25. Paclitaxel-loaded niosomes for intravenous administration: pharmacokinetics and tissue distribution in rats

SEZGİN BAYINDIR Z., BEŞİKCİ A., YÜKSEL N.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.45, sa.6, ss.1403-1412, 2015 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

26. Substrate Metabolism in the Diabetic Heart

BEŞİKCİ A.
DIABETIC CARDIOMYOPATHY: BIOCHEMICAL AND MOLECULAR MECHANISMS , cilt.9, ss.65-76, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

27. Synthesis, Biological and Computational Evaluation of Novel Oxindole Derivatives as Inhibitors of Src Family Kinases

KILIÇ KURT Z., BEŞİKCİ A., Olgen S.
LETTERS IN DRUG DESIGN & DISCOVERY , cilt.10, sa.8, ss.713-718, 2013 (SCI-Expanded, Scopus) identifier identifier

28. Synthesis, biological evaluation and docking studies of new pyrrolo[2,3-d] pyrimidine derivatives as Src family-selective tyrosine kinase inhibitors

Dincer S., Cetin K. T., BEŞİKCİ A., Olgen S.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , cilt.28, sa.5, ss.1080-1087, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

29. Special Issue: New Trends in Pharmaceutical Sciences 10th International Symposium on Pharmaceutical Sciences (10th ISOPS) June 26 to 29, 2012 Ankara University Faculty of Pharmacy, Ankara-Turkey

YÜKSEL N., BEŞİKCİ A.
CURRENT DRUG DELIVERY , cilt.10, sa.1, ss.2, 2013 (SCI-Expanded, Scopus) identifier

30. Niosomes encapsulating paclitaxel for oral bioavailability enhancement: preparation, characterization, pharmacokinetics and biodistribution

SEZGİN BAYINDIR Z., BEŞİKCİ A., VURAL N., YÜKSEL N.
JOURNAL OF MICROENCAPSULATION , cilt.30, sa.8, ss.796-804, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

31. Carvedilol suppresses fatty acid oxidation and stimulates glycolysis in C2C12 cells

BEŞİKCİ A., Suzmecelik E., ÖZÇELİKAY A. T.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , cilt.90, sa.8, ss.1087-1093, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

32. Acute Regulation of Cardiac Metabolism by the Hexosamine Biosynthesis Pathway and Protein O-GlcNAcylation

Laczy B., Fueloep N., BEŞİKCİ A., Rosiers C. D., Chatham J. C.
PLOS ONE , cilt.6, sa.4, 2011 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

33. Protective action of doxycycline against diabetic cardiomyopathy in rats

YARAŞ N., Sariahmetoglu M., BİLGİNOĞLU A., Aydemir-Koksoy A., BEŞİKCİ A., Turan B., et al.
BRITISH JOURNAL OF PHARMACOLOGY , cilt.155, sa.8, ss.1174-1184, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

34. Trimetazidine revisited: A comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine

BEŞİKCİ A., Oezkan S. A.
Cardiovascular Therapeutics , cilt.26, sa.2, ss.147-165, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

35. alpha-Lipoic acid increases cardiac glucose oxidation independent of AMP-activated protein kinase in isolated working rat hearts

BEŞİKCİ A., Wagg C., Lopaschuk T. P., Keung W., Lopaschuk G. D.
BASIC RESEARCH IN CARDIOLOGY , cilt.102, sa.5, ss.436-444, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

36. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts

BEŞİKCİ A., Guner S., Arioglu E., ÖZAKCA GÜNDÜZ I., ÖZÇELİKAY A. T., Altan V. M.
Canadian Journal of Physiology and Pharmacology , cilt.85, sa.5, ss.527-535, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

37. Impact of lactate in the perfusate on function and metabolic parameters of isolated working rat heart

BEŞİKCİ A.
MOLECULAR AND CELLULAR BIOCHEMISTRY , cilt.296, sa.1-2, ss.121-127, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

38. The effects of chronic trimetazidine treatment on mechanical parameters and fatty acid oxidation in 14-week diabetic rat hearts

BEŞİKCİ A., Guner S., Arioglu E., ÖZAKCA GÜNDÜZ I., Ozcelikay T., Altan V. M.
CARDIOVASCULAR DRUGS AND THERAPY , cilt.20, sa.6, ss.417, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

39. Substrate metabolism and function of fructose-fed rat heart

Guner S., BEŞİKCİ A., Arioglu E., ÖZAKCA GÜNDÜZ I., Altan V. M., ÖZÇELİKAY A. T.
CARDIOVASCULAR DRUGS AND THERAPY , cilt.20, sa.6, ss.408, 2006 (SCI-Expanded, Scopus) identifier

40. The metabolic approach in the treatment of cardiac dysfunction in diabetes Di̇yabeti̇k kalpte görülen mekani̇k ve metaboli̇k deǧi̇şi̇mler ve bunlarin tedavi̇si̇nde metaboli̇k yaklaşim

Onay-Beşikci A., Güner Ş.
Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.35, sa.4, ss.297-317, 2006 (Scopus) Sürdürülebilir Kalkınma identifier

41. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply

BEŞİKCİ A., Sambandam N.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , cilt.84, sa.11, ss.1215-1222, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

42. Regulation of cardiac energy metabolism in newborn

BEŞİKCİ A.
MOLECULAR AND CELLULAR BIOCHEMISTRY , cilt.287, sa.1-2, ss.1-11, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

43. gAd-globular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts

BEŞİKCİ A., Altarejos J., Lopaschuk G.
JOURNAL OF BIOLOGICAL CHEMISTRY , cilt.279, sa.43, ss.44320-44326, 2004 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

44. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats

Atkinson L., Kozak R., Kelly S., BEŞİKCİ A., Russell J., Lopaschuk G.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM , cilt.284, sa.5, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

45. Relative importance of malonyl CoA and carnitine in maturation of fatty acid oxidation in newborn rabbit heart

Besikci A., Campbell F., Hopkins T., Dyck J., Lopaschuk G.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY , cilt.284, sa.1, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. İntravenöz Linezolid Tedavisinden Oral Tedaviye Geçiş: Bir Olgu Raporu

Kayra T., Önür N., Onay-Beşikci A., Er R. E., Özkan H.
2. Olgularla Klinik Eczacılık Çalıştayı, İstanbul, Türkiye, 8 - 09 Haziran 2022, ss.23, (Özet Bildiri)
Kitaplar 8

1. Beta Arrestin

BEŞİKCİ A., GÜVEN B.
Kalp Yetersizliği ve Tedavisinde Yeni Hedefler, , Editör, Tükiye Klinikleri, ss.159-161, 2023

2. Herpes Enfeksiyonlarında Kullanılan İlaçlar

GÜVEN B., ARSLAN E., BEŞİKCİ A.
Viral Enfeksiyonlarda Güncel Tedavi Yaklaşımları ve İmmünizasyon, Erdinç Meral, Editör, Ortadoğu, Ankara, ss.61-68, 2021

3. C Vitamini, D Vitamini, Çinko: COVID-19 Tedavisinde Mikro Besinlerden Makro Beklenti Gerçekçi mi?

GÜVEN B., Kara Z., BEŞİKCİ A.
Türkiye Klinikleri, Birengel Serhat, Balık İsmail, Editör, Ortadoğu, Ankara, ss.53-58, 2021

4. EczÇEP-Eczacılık Fakülteleri Müfredat Detay Çalışması

AKALIN URUŞAK E., AKEV N., ERGİNER Y., GÜZELDEMİRCİ N., TOKER S., KOLAK U., et al.
Kapitta Yayıncılık, 2017

5. TÜRK FARMAKOPESl-ll MONOGRAFLAR (Avrupa Farmakopesi Adaptasyonu) - 2016

ÖZKAN Y., SALTAN H. G., SARAÇ TARHAN S., ÖZKAN S. A., AYDIN A., SÜZEN H. S., et al.
T.C. Sağlık Bakanlığı Türkiya ilaç veTıbbl Cihaz. Kurumu, Ankara, 2016

6. Türk Farmakopesi II - Avrupa Farmakopesi Adaptasyonu

YÜKSEL N., ÖZKAN S. A., ÖZKAN Y., KILIÇARSLAN M., SÜZEN S., SALTAN H. G., et al.
Anıl Reklam Matbaa Ltd. Şti. / Ankara, 2016

7. Substrate Metabolism in the Diabetic Heart

Onay-Besikci A.
Diabetic Cardiomyopathy, Belma Turan and Naranjan S. Dh, Editör, Springer, London/Berlin , New York, ss.65-76, 2013

8. Regulation of Fatty Acid Oxidation by Malonyl CoA in Cardiac Muscle Tissue

Onay-Besikci A., Lopaschuk G. D.
Advances in Molecular and Cell Biology, G. van der Vusse, Editör, Elsevier Science, Oxford/Amsterdam , Amsterdam, ss.223-241, 2003
Metrikler

Yayın

96

Yayın (WoS)

48

Yayın (Scopus)

42

Atıf (WoS)

927

H-İndeks (WoS)

17

Atıf (Scopus)

920

H-İndeks (Scopus)

17

Atıf (TrDizin)

3

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

3

Proje

14

Tez Danışmanlığı

3

Açık Erişim

9
BM Sürdürülebilir Kalkınma Amaçları